全文获取类型
收费全文 | 785篇 |
免费 | 53篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 9篇 |
妇产科学 | 12篇 |
基础医学 | 88篇 |
口腔科学 | 11篇 |
临床医学 | 63篇 |
内科学 | 173篇 |
皮肤病学 | 6篇 |
神经病学 | 54篇 |
特种医学 | 22篇 |
外科学 | 132篇 |
综合类 | 13篇 |
预防医学 | 23篇 |
眼科学 | 97篇 |
药学 | 90篇 |
中国医学 | 5篇 |
肿瘤学 | 37篇 |
出版年
2023年 | 3篇 |
2022年 | 23篇 |
2021年 | 69篇 |
2020年 | 22篇 |
2019年 | 22篇 |
2018年 | 20篇 |
2017年 | 14篇 |
2016年 | 26篇 |
2015年 | 26篇 |
2014年 | 43篇 |
2013年 | 33篇 |
2012年 | 58篇 |
2011年 | 58篇 |
2010年 | 36篇 |
2009年 | 21篇 |
2008年 | 40篇 |
2007年 | 45篇 |
2006年 | 58篇 |
2005年 | 48篇 |
2004年 | 29篇 |
2003年 | 27篇 |
2002年 | 20篇 |
2001年 | 8篇 |
2000年 | 10篇 |
1999年 | 9篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1969年 | 2篇 |
1916年 | 1篇 |
排序方式: 共有840条查询结果,搜索用时 31 毫秒
81.
I-Jun?LauEmail author Dean?Smith Robin?Aitchison Norbert?Blesing Pamela?Roberts Andrew?Peniket Kwee?Yong Neil?Rabin Karthik?Ramasamy 《Annals of hematology》2015,94(4):643-649
Treatment options are limited in myeloma relapsed or refractory to both bortezomib and lenalidomide (double-relapsed/refractory multiple myeloma; DRMM). Bendamustine is an antitumour agent that has efficacy in relapsed myeloma. We retrospectively analysed data from 30 DRMM patients who received a combination of bendamustine, thalidomide and dexamethasone (BTD) in 28-day treatment cycles. Bendamustine was administered with a cumulative dose of up to 200 mg/m2. Thalidomide (50–150 mg) was given daily as tolerated, and dexamethasone was given at an equivalent dose of up to 160 mg per cycle. A median of 5 (2–9) treatment cycles were administered per patient. Twenty-six patients (87 %) achieved stable disease or better. At a median follow-up time of 12.1 (2.3–21.5) months, median (95 % CI) progression-free survival and overall survival were 4.0 (2.6–5.3) months and 7.2 (5.2–9.2) months, respectively. The most common grade 3–4 adverse events were haematological: anaemia (n?=?8, 34.8 %), neutropenia (n?=?16, 69.6 %) and thrombocytopenia (n?=?10, 43.5 %). Non-haematological toxicities included pain (n?=?3, 13.0 %), infection (n?=?7, 30.4 %) and sensory neuropathy (n?=?1, 4.3 %). We propose that BTD is a viable salvage treatment option for DRMM patients. 相似文献
82.
Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia
下载免费PDF全文
![点击此处可从《Transplant infectious disease》网站下载免费的PDF全文](/ch/ext_images/free.gif)
83.
84.
85.
Outcomes following balloon mitral valvuloplasty in pregnant females with mitral stenosis and significant sub valve disease with severe decompensated heart failure
下载免费PDF全文
![点击此处可从《Journal of interventional cardiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
86.
Vickneswaren Thever Ramasamy Lavitha Sivapatham Sonia Regina Grover Sharmila Saraswathy Shanmugam Muralitharan Ganesalingam 《Journal of pediatric and adolescent gynecology》2021,34(1):61-64
BackgroundUterine torsion is a rare event, which mostly reported in females with a gravid uterus and is exceptionally rare in children.CaseA 9-year-old girl presented with 3 days of intermittent lower abdominal pain. Ultrasound revealed an ovarian mass, but laparotomy revealed an ischemic enlarged ovary and uterus rotated 180°. No reperfusion occurred after 60 minutes. A subtotal hysterectomy and right salpingoophorectomy were thus performed.ConclusionUterine and adnexal torsion presents with symptoms similar to those of adnexal torsion. Delays in diagnosis and referral continue to be an issue, resulting in suboptimal outcomes. Uterine torsion, although exceedingly rare in childhood, appears to occur only in the setting of ovarian masses, which provide the impetus for the rotational force to the elongated cervix of the prepubertal uterus. 相似文献
87.
ObjectiveTo investigate the antibacterial properties of the five metal oxide nanoparticles viz., Al2O3, Fe2O3, CeO2, ZrO2 and MgO against urinary tract infectious pathogens viz., Pseudomonas sp., Enterobacter sp., Klebsiella sp., Escherichia coli (E. coli), Proteus morganii (P. morganii) and Staphylococcus aureus (S. aureus).MethodsThe antibacterial activity of the five different nanoparticles was assessed by well diffusion method. Different concentrations of the nanoparticles were analyzed by minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) techniques. Finally, the potential nanoparticle Al2O3 which showed maximum antibacterial sensitivity was also subjected for the time kill assay method.ResultsAmong the nanoparticles, Al2O3 nanoparticle showed maximum sensitivity (16.00±0.21) mm against E. coli. None of the nanoparticles showed activity against Pseudomonas sp. The MIC results also revealed that, the Al2O3 nanoparticle showed maximum inhibition at the concentration of 5 μg/mL against E. coli, followed by 10 μg/mL against Klebsiella sp. and P. morganii, respectively. Moreover, the time kill assay revealed that, the bacterial growth was maximum inhibited at the concentration of 5 μg/mL from the 2nd h.ConclusionsIt can be concluded from the present findings that, the Al2O3 nanoparticle can be used as an alternative antibacterial agent for the urinary bacterial diseases after completing successful clinical trials. 相似文献
88.
89.
90.